|
|
Article: Study shows risedronate sodium tablets helped preserve bone quality at 5 years.
- Article from:
- Biotech Week
- Article date:
- October 15, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 OCT 15 - (NewsRx.com & NewsRx.net) -- Actonel (risedronate sodium tablets) helped preserve important aspects of bone quality at 5 years in postmenopausal women with osteoporosis, according to new research presented at the 25th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR).
"Studies suggest that bone quality may be an important contributor to bone strength and fracture resistance. These new data provide value in learning how therapies such as risedronate affect bone quality," said principal investigator Eleftherios P. Paschalis, PhD, Ludwig Boltzmann Institute for Osteology, Vienna, Austria. "However, additional studies are ...